Sep 22 |
Rhythm: Upcoming sNDA Label Expansion IMCIVREE Isn't The Only Catalyst On Deck
|
Sep 21 |
Rhythm Pharmaceuticals, Inc. (RYTM): Short Seller Sentiment is Bearish
|
Sep 18 |
Strength Seen in Rhythm Pharmaceuticals (RYTM): Can Its 7.4% Jump Turn into More Strength?
|
Sep 17 |
Rhythm Pharma draws bullish view at JMP on opportunity in rare genetic obesities
|
Sep 10 |
Biotech Stock Near Buy Point Amid Impressive Sales Track Record
|
Sep 6 |
Four Biotech Stocks Rally Toward Buy Points As Funds Load Up
|
Aug 29 |
Rhythm: Pivotal Moment Approaching In Hypothalamic Obesity (Rating Upgrade)
|
Aug 28 |
Biotech Stock Roundup: REGN's Drug Approval, LXRX, RYTM Stocks Gain on Update & More
|
Aug 27 |
High Growth Tech Stocks To Watch In August 2024
|
Aug 26 |
FDA sets target action date for Rhythm's sNDA for Imcivree
|